The U.S. FDA is asking Novavax (NASDAQ:NVAX) to conduct an additional randomized, controlled study of its COVID-19 vaccine ...

Among the major classes of RNAs in the cell, tRNAs remain the most difficult to characterize via deep sequencing approaches, as tRNA structure and nucleotide modifications can each interfere with cDNA ...

Bin Wu, associate professor in the department of Biophysics and Biophysical Chemistry at the School of Medicine, visited ...

Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach and enhance results.

BioNTech SE (BNTX) reports a net profit for Q4 2024 amidst a challenging year, with strategic advancements in oncology and ...

Super Micro Computer retained the top spot for the most shorted S&P 500 stock as a percentage of float in March. Super Micro ...

In March, short sellers collectively increased their negative bets on the broader healthcare industry. Read more details here ...

Southern RNA is an Australian CDMO specialising in producing nucleic acid products that support the clinical development of ...

One researchers explained that bacteria do a really, really good job of keeping the sequence you want and the sequence that you get.

The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the mRNA synthesis and ...

A review paper published last year in European Journal of Medicinal Chemistry characterized Myc as the “oncogene from ...

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...